The Role of Artificial Intelligence in the Pharmaceutical Sector: A Comprehensive Analysis of its Application from the Discovery Phase to Industrial Implementation
Prajwal S Shinde,Ashish Y Pawar,Swati G Talele
DOI: https://doi.org/10.25258/ijddt.13.4.70
2023-12-25
International Journal of Drug Delivery Technology
Abstract:The incorporation of artificial intelligence (AI) technology into the pharmaceutical sector is a groundbreaking revolution, promising to enhance drug development significantly by boosting speed, efficiency, and effectiveness. This transformative journey encompasses several key facets, notably the sophisticated analysis of complex data, the optimization of drug delivery systems, the acceleration of drug discovery, the identification of valuable biomarkers and drug candidates, and the fine-tuning of treatment outcomes. Beyond these crucial strides, AI is reshaping healthcare at large, elevating decision-making processes, and deepening our understanding of diseases and pharmaceuticals. The broader domains within this AI-driven transformation encompass themes such as “Revolutionizing Pharmaceutical Product Development Through AI,” where AI platforms like the Chemputer successfully synthesize compounds and estimate granulation completion times, improving production efficiency. In “Transforming Pharmaceutical Manufacturing with AI, “AI optimizes manufacturing processes, further enhancing efficiency.” Enhancing Clinical Trial Design Through AI” harnesses AI to improve patient selection and adherence, utilizing genome and exposome profiles for precise and efficient clinical trials. AI also proves valuable in preclinical phases, predicting lead compounds. Moreover, AI extends its influence to brand recognition and market positioning of pharmaceutical products, leveraging technology and e-commerce platforms for distinct product identities and effective marketing strategies. In “Convergence of AI and Nanomedicine,” AI delves into complex formulation development, optimizing drug delivery methods via molecular analysis and simulation tools. Furthermore, AI’s role in addressing challenges in the pharmaceutical market, such as reducing financial burdens and risks related to virtual screening, is pivotal. The sector’s substantial growth and its integration into pharmaceutical companies’ strategies through collaborations signify a promising future for AI in healthcare.In summary, the incorporation of AI in the pharmaceutical industry holds immense potential for enhancing production processes, clinical trial design, market positioning, nanomedicine, and overall industry efficiency. These collective advancements mark a transformative era in pharmaceutical innovation and patient care.